Free radicals and trace elements

Journal of Trace Elements in Experimental Medicine

Volumn 11, Issue 2-3, 1998, Pages 209-217

  Hirayama, Kimiko ^a   Yasutake, Akira ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE FOR MINAMATA DISEASE   (Japan)

Author keywords

Glutathione; Heavy metals; Oxidative stress; Trace elements

Indexed keywords

CARBONYL IRON; COPPER ION; ENVIRONMENTAL CHEMICAL; FERROUS ION; FREE RADICAL; GLUTATHIONE; HEAVY METAL; HYDROGEN PEROXIDE; IRON DERIVATIVE; IRON DEXTRAN; METHYLMERCURY; NITRILOTRIACETATE IRON; PROTEIN; REACTIVE OXYGEN METABOLITE; THIOL GROUP; TRACE ELEMENT;

ARTICLE; CARCINOGENESIS; CONJUGATION; GLUTATHIONE METABOLISM; HEART DISEASE; IRON OVERLOAD; KIDNEY; LIPID PEROXIDATION; LIVER; LIVER CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031927378     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-670X(1998)11:2/3<209::AID-JTRA11>3.0.CO;2-V     Document Type: Article

References (60)

1. Bacon BR, Britton RS: The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 11:127-137, 1990.
2. Halliwell HB, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85, 1990.
3. Hogberg J, Bergstrand A, Jakobsson SV: Lipid peroxidation of rat-liver microsomes: Its effect on the microsomal membrane-bound microsomal enzymes. Eur J Biochem 37:51-59, 1973.
4. Mak IT, Weglicki WB: Characterization of iron-mediated peroxidative injury in isolated hepatic lysosomes. J Clin Invest 75:58-63, 1985.
5. Bacon BR, O'Neill R, Park CH: Iron induced peroxidative injury to isolated rat hepatic mitochondria. J Free Rad Biol Med 2:339-347, 1986.
6. Peters SW, Jones BM, Jacobs A, Wagstaff M: "Free" ion and lipid peroxidation in the plasma of patients with ion overload. In Spike GMJ, Crichton RR, Mazurier J (eds): "Proteins of Iron Storage and Transport." New York: Elsevier Science Publishers, pp 321-324, 1985.
7. Dillard CJ, Tappel AL: Volatile hydrocarbon and carbonyl products of lipid peroxidation: A comparison of penthane, ethane, hexanal and acetone as in vivo indices. Lipids 14:969-995, 1979.
8. Galleano M, Puntarulo S: Hepatic chemiluminescence and lipid peroxidation in mild iron overload. Toxicology 76:27-38, 1992.
9. Dougherty JJ, Croft WA, Hoekstra WG: Effects of Ferrous chloride and iron-dextran on lipid peroxidation in vivo in vitamin E and selenium adequate and deficient rats. J Nutr 111:1784-1796, 1981.
10. Bacon BR, Tavill AS, Brittenham GM, Park CH, Recknagel RO: Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 71:429-439, 1983.
11. Younes M, Eberhardt I, Lemoine R: Effect of iron overload on spontaneous and xenobiotic-induced lipid peroxidation in vivo. J Appl Toxicol 9:103-108, 1989.
12. Dresow B, Albert C, Zimmerman I, Nielsen P: Ethane exhalation and Vitamin E/Ubiquinol status as markers of lipid peroxidation in ferrocene iron-loaded rats. Hepatology 21:1099-1105, 1995.
13. Burkitt MJ, Mason RP: Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: An ESR spin-trapping investigation. Proc Natl Acad Sci USA 88:8440-8444, 1991.
14. Figueiredo MS, Baffa O, Neto JB, Zago MA: Liver injury and generation of hydroxyl free radicals in experimental secondary hemochromatosis. Res Exp Med 193:27-37, 1993.
15. Minotti G: Sources and role of iron in lipid peroxidation. Chem Res Toxicol 6:134-146, 1993.
16. Dedon PC, Goldberg IH: Free-radical mechanisms involved in the formation of sequence-dependent bistrand DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem Res Toxicol 5:311-332, 1992.
17. Kasprzak KS: The role of oxidative damage in metal carcinogenicity. Chem Res Toxicol 4:604-615, 1991.
18. Pietrangelo A, Cossarizza A, Monti D, Ventuna E, Franceschi C: DNA repair in lymphocytes from human and rats with chronic iron overload. Biochem Biophys Res Comm 154:698-704, 1988.
19. Okada S, Hamazaki S, Toyokuni S, Midorikawa O: Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. Br J Cancer 60:708-711, 1989.
20. Li J-L, Okada S, Hamazaki S, Ebina Y, Midorikawa O: Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 47:1867-1869, 1987.
21. Younes M, Wess A: The role of Iron in t-butyl hydroperoxide-induced lipid peroxidation and hepatotoxicity in rats. J Appl Toxicol 10:313-317, 1990.
22. Gunther T, Grossrau R, Hollriegl V, Vormann J: Effects of Fe, salicylate and Zn on metallothionein and lipid peroxidation. J Trace Elem Electrolytes Health Dis 5:95-100, 1991.
23. Mackinnon M, Clayton C, Plummer J, Ahern M, Cmielewski P, Ilsley A, Hall P: Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model. Hepatology 21: 1083-1088, 1995.
24. Yasutake Y, Adachi T, Suda I, Hirayama K: Effect of Fe-overload on the biotransformation of methylmercury in rat. Jpn J Toxicol Environ Health 39:106-113, 1993.
25. Ames BN: Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative disease. Science 221:1256-1264, 1983.
26. Cerutti PA:Prooxidant status and tumor promotion. Science 227:375-381, 1985.
27. Smith AG, Cabrai JRP, Carthew P, Francis JE, Manson MM: Carcinogenicity of iron conjugation with chlorinated environmental chemical, hexachlorobenzene, in C57BL/10ScSn mice. Int J Cancer 43:492-496, 1989.
28. Smith AG, Francis JE, Carthew P: Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah responsive C57BL/10ScSn mice. Carcinogenesis 11:437-444, 1990.
29. Youdim MBH, Ben-Shachar D, Yehuda S, Riederer P: The role of iron in the basal ganglion. Adv Neurol 53:155-162, 1990.
30. Youdim MBH, Ben-Shachar D, Riederer P: Iron in brain function and dysfunction with emphasis on Parkinson's disease. Eur Neurol 31 (Suppl. 1):34-40, 1991.
31. Ben-Shachar D, Eshel G, Riederer P, Youdim MBH: Role of iron and iron chelation in dopaminergicinduced neurodegeneration: Implication for Parkinson's disease. Ann Neurol 32:S105-S110, 1992.
32. Youdim MBH, Ben-Shachar D, Riederer P: Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand 126:47-54, 1989.
33. DeBoer DA, Clark RE: Iron chelation in myocardial preservation after ischemia-reperfusion injury: The importance of pretreatment and toxicity. Ann Thoracic Surg 53:412-418, 1992.
34. Katoh S, Toyama J, Kodama I, Akita T, Abe T: Deferoxamine, an iron chelator, reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischemia-reperfusion. J Mol Cell Cardiol 24:1267-1275, 1992.
35. Hochstein P, Kumar KS, Forman SJ: Lipid peroxidation and the cytotoxicity of copper. Ann NY Acad Sci 355:240-248, 1980.
36. Dougherty JJ, Hoekstra WG: Effects of vitamin E and selenium on copper-induced lipid peroxidation in vivo and on acute copper toxicity. Proc Soc Exp Biol Med 169:201-208, 1982.
37. Dillard CJ, Tappel AL: Lipid peroxidation and copper toxicity in rats. Drug Chem Toxicol 7:477-487, 1984.
38. Hanna PM, Mason RP: Direct evidence for inhibition of free radical formation from Cu(I) and hydrogen peroxide by glutathione and other potential ligands using the EPR spin-trapping technique. Arch Biochem Biophys 295:205-213, 1992.
39. Kadiiska MB, Hanna PM, Hernandez L, Mason RP: In vivo evidence of hydroxyl radical formation after acute copper and ascorbic acid intake: Electron spin resonance spin-trapping investigation. Mol Pharmacol 42:723-729, 1992.
40. Kadiiska MB, Hanna PM, Jordan SJ, Mason RP: Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: In vivo spin trapping investigation. Mol Pharmacol 44:222-227, 1993.
41. Kadiiska MB, Hanna PM, Mason RP: In vivo ESR spin trapping evidence for hydroxyl radical-mediated toxicity of paraquat and copper in rats. Toxicol Appl Pharmacol 123:187-192, 1993.
42. Sinha BK, Katki AG, Batist G, Cowan KH, Myers CE: Differential formation of hydroxyl radicals by adriamycine in sensitive and resistant MCF-7 human breast tumor cells: Implications for the mechanism of action. Biochemistry 26:3776-3781, 1987.
43. Kramer RA, Zakher I, Kim G: Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science 241:694-697, 1988.
44. Galiazzo F, Schiesser A, Rotilio G: Glutathione peroxidase in yeast. Presence of the enzyme and induction by oxidative conditions. Biochem Biophys Res Comm 147:1200-1205, 1987.
45. Freedman JH, Ciriolo MR, Peisach J: The role of glutathione in copper metabolism and toxicity. J Biol Chem 264:5598-5605, 1989.
46. Sideris EG, Charalambous SC, Tsolomyty A, Katsaros N: Mutagenesis, carcinogenesis and the metal elements - DNA interaction. Progress in Clinical and Biological Research, 259:13-25, 1988.
47. Tkeshelashvili LK, McBride T, Spence K, Loeb LA: Mutation spectrum of copper-induced DNA damage. J Biol Chem 266:6401-6402, 1991.
48. Agarwal K, Sharma A, Talukder G: Clastogenic effects of copper sulphate on the bone marrow chromosomes of mice in vivo. Mutation Res 243:1-6, 1990.
49. Andersen HR, Andersen O: Effects of dietary α-tocopherol and β-carotene on lipid peroxidation induced by methyl mercuric chloride in mice. Pharmacol Toxicol 73:192-201, 1983.
50. Simpson RB: Association constants of methylmercury with sulfhydryl and other bases. J Amer Chem Soc 83:4711-4717, 1961.
51. Hirayama K, Yasutake Y, Inoue M: Effect of sex hormones on the fate of methylmercury and glutathione metabolism in mice. Biochem Pharmacol 36:1919-1924, 1987.
52. Woods JS, Davis HA, Baer RP: Enhancement of gammer-glutamylcysteine synthetase mRNA in rat kidney by methyl mercury. Arch Biochem Biophys 296:350-353, 1992.
53. Yasutake A, Hirayama K: Acute effects of methylmercury on hepatic and renal glutathione metabolism in mice. Arch Toxicol 68:512-516, 1994.
54. Nielson JB, Andersen HR, Andersen O, Starklint H: Mercuric chloride-induced kidney damage in mice: Time course and effect of dose. J Toxicol Environ Health 34:469-483, 1991.
55. Standeven AM, Wetterhahn KE: Possible role of glutathione in chromium (VI) metabolism and toxicity in rats. Pharmacol Toxicol 69:469-476, 1991.
56. Chin TA, Templeton DM: Protective elevation of glutathione and metallothionein in cadmium-exposed mesangial cells. Toxicology 77:145-156, 1993.
57. Hart BA, Voss GW, Willean CL: Pulmonary tolerance of cadmium following cadmium aerosol pretreatment. Toxicol Appl Pharmacol 101:447-460, 1989.
58. Li W, Chou I-N: Effects of arsenate on the cytoskeleton and cellular glutathione levels in cultured cells. Toxicol Appl Pharmacol 114:132-139, 1992.
59. Miura K, Clarkson TW: Reduced methylmercury accumulation in a methylmercury-resistant rat pheochromocytoma PC12 cell line. Toxicol Appl Pharmacol 118:39-45, 1993.
60. Kromidas L, Trombetta LD, Jamal IS: The protective effects of glutathione against methylmercury cytotoxicity. Toxicol Lett 51:67-80, 1990.